These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6238928)

  • 21. [In vitro antibacterial activity and beta-lactamase stability of meropenem].
    Poiată A; Tuchiluş C; Bădicuţ I; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):589-94. PubMed ID: 14756067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative in vitro activities of norfloxacin (MK-0366) and six commonly used antimicrobial agents against 199 urinary isolates showing various degrees of antibiotic resistance.
    Corigliano BE; Appleman MD; Heseltine PN; Leedom JM
    Diagn Microbiol Infect Dis; 1984 Apr; 2(2):101-6. PubMed ID: 6232085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Distribution and changes in the susceptibility of bacteria isolated from clinical samples. III].
    Deguchi K; Fukayama S; Nishimura Y; Nishike A; Oda S; Sato S; Matsumoto Y; Ikegami R; Yokota N; Tanaka S
    Jpn J Antibiot; 1985 Jun; 38(6):1603-18. PubMed ID: 3930806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Rapid determination of the minimal inhibitory concentration of an antibiotic by measuring bacterial ATP (author's transl)].
    Fauchère JL; Simonet M; Descamps P; Véron M
    Ann Microbiol (Paris); 1982; 133(2):293-9. PubMed ID: 7044219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Research on the in vitro antibacterial activity of gentamicin].
    Petrini M; Cava L; Grassi L
    Minerva Med; 1967 Nov; 58(95 Suppl):4196-4207. PubMed ID: 4966209
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro emergence of quinolone-resistant mutants of Escherichia coli, Enterobacter cloacae, and Serratia marcescens.
    Watanabe M; Kotera Y; Yosue K; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1990 Jan; 34(1):173-5. PubMed ID: 2183709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Correlation of agar diffusion tests and serial dilution tests. Demonstration of regression lines for gentamycin].
    Wahlig H; Hameister W; Naumann P; Linzenmeier G; Neussel H
    Int J Clin Pharmacol; 1973 Jul; 7(4):328-39. PubMed ID: 4199252
    [No Abstract]   [Full Text] [Related]  

  • 28. [Susceptibility of clinical isolates to aztreonam].
    Nagasawa Z; Nishimura T; Nagumo F; Ueda H; Tadano J; Katoh O; Yamada H
    Jpn J Antibiot; 1989 Jun; 42(6):1257-70. PubMed ID: 2507799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In-vitro synergism between beta-lactamines. I. Anti-bacterial action of ampicillin-cloxacillin combination on Gram-negative bacteria].
    Denis F; Geslin M; Brisou J
    C R Seances Soc Biol Fil; 1973; 167(12):1939-43. PubMed ID: 4214512
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on the present state of resistance to framycetin among strains of staphylococci, enterobacteriaceae and pseudomonas.
    Knothe H
    Arzneimittelforschung; 1973 Dec; 23(12):1759-60. PubMed ID: 4205906
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro activity of carbenicillin against Pseudomonas using the disc diffusion method.
    Washington JA; Hall MM; Fausch CJ; Brackin KL
    Mayo Clin Proc; 1973 Oct; 48(10):718-21. PubMed ID: 4200876
    [No Abstract]   [Full Text] [Related]  

  • 32. Norfloxacin (MK-0366, AM-715): in vitro activity and cross-resistance with other organic acids including quality control limits for disk diffusion testing.
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1983 Jun; 1(2):165-72. PubMed ID: 6232084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibacterial activity of norfloxacin.
    Norrby SR; Jonsson M
    Antimicrob Agents Chemother; 1983 Jan; 23(1):15-8. PubMed ID: 6219617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures.
    Wiegand I; Geiss HK; Mack D; Stürenburg E; Seifert H
    J Clin Microbiol; 2007 Apr; 45(4):1167-74. PubMed ID: 17287329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of technical factors in the determination of minimal inhibitory concentration by microdilution].
    Forey F; Coulet M; Brun Y; Fleurette J
    Pathol Biol (Paris); 1985 May; 33(5):341-9. PubMed ID: 3162138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae to cefoxitin and BL-S786.
    Meyer RD
    J Antibiot (Tokyo); 1977 Apr; 30(4):326-9. PubMed ID: 324961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The interaction patterns of combined antibacterial agents. Experiments with two agardiffusion methods.
    Mouton RP; Koelman A
    Chemotherapy; 1966; 11(1):10-26. PubMed ID: 4959585
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro activity of enoxacin compared with norfloxacin and amikacin.
    van der Auwera P; de Moor G; Lacroix G; Mambour A; Rossion N; Schuyteneer F
    Eur J Clin Microbiol; 1985 Feb; 4(1):55-8. PubMed ID: 3157568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug resistance of urinary tract pathogens cultured from ambulatory patients in the community in 1969.
    Bauer AW
    J Urol; 1971 Nov; 106(5):750-6. PubMed ID: 5000524
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
    Croize J; Le Noc P; Bryskier A; Robert J
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.